Search PubMed⌕ Search

Biomedical subjects

J F Martin

Publications and source records attributed to J F Martin.

At least 253 records · Page 14Linked to original sources

Abnormal intrapulmonary platelet production: a possible cause of vascular and lung disease.

It is postulated that platelets are not produced by megakaryocyte budding within the bone marrow but by physical fragmentation in the pulmonary circulation. Alterations in the nature of the production site (the pulmonary vessels and their concomitant biochemical environment) or changes in the antecedent megakaryocyte cytoplasmic volumes with a concomitant alteration in protein structure can produce platelets with a mean volume larger than normal. If such platelets are more reactive then they may be involved in atherogenesis and arterial thrombosis. Furthermore several pulmonary pathological states may arise from dysfunction during pulmonary platelet production.

Blood Platelets↗

A new method giving a two criteria diagnosis of venous occlusion using isotope imaging of 99mTc-labelled fibrinogen.

A new method for the diagnosis of venous occlusion involves three stages: first, injection of 99mTc-labelled fibrinogen into a distal vein in the suspected limb with a dynamic gamma scan of venous flow; second, a static pool scan of both limbs to show the anatomy of the veins seen in the dynamic scan and third, a later static scan showing 99mTc-fibrinogen associated with thrombus. In occlusion, absence of flow in the dynamic scan corresponds to the presence of isotope in thrombus in the second static scan. The test uses a low-volume, low-radioactivity injection and may be repeated many times.

Adult↗

A biological approach to the platelet survival curve with criticism of previous interpretations.

The biological mechanisms of platelet destruction must be correctly identified before platelet survival curves can be interpreted. This report develops a theory of platelet destruction which is compared with experiments performed on platelets labelled with the radioactive isotope 51Cr. Platelet destruction rate is a complicated function of platelet number and the thrombokinetic destruction state of the body. A linear approximation of this function shows that destruction is dominated by constant and random consumption. A second order non-linear approximation shows the effect of 'platelet crowding'. This theoretical study explains the difference between predicting the complete platelet survival curve from only two experimental points (in the linear approximation) and the methods of curve fitting currently recommended by the International Committee for Standardization in Haematology. It indicates that the curve fitting of known functional forms to experimental data usually results in an under interpretation of the observations and dilutes the diagnostic potential of the platelet survival curve.

Animals↗

Measurement of the density of human platelets and its relationship to volume.

New methods are described for platelet isolation and buoyant density determination using low-speed centrifugation in continuous density gradients of Percoll. The conditions used do not induce loss of granule or cytoplasmic markers and enable reproducible platelet frequency distributions to be obtained in linear density gradients. Such frequency distributions are normal with a mode of 1.0645 +/- 0.0015 g cm-3 (mean +/- SD, n=20). Platelets fixed in 0.1% glutaraldehyde show a modal density of 1.0712 +/- 0.0005 g cm-3. Content of protein, lactate dehydrogenase, beta-thromboglobulin and 3H-serotonin correlate closely with platelet numbers throughout the density distribution. The frequency distribution of platelet volume between 2.2 and 21 fl fits a log normal model and cell volume in density subfractions from the most dense to the least dense also approximate log normality. There is a positive correlation between mean platelet volume and buoyant density with a small increment between the least and the most dense extremes. Platelet subfractions separated by volume using a FACS II cell sorter differ substantially from each other in cell volume but the difference in mean density of four different volume fractions in negligible. In discontinuous density gradients of Stractan factors other than platelet density must influence the separation of platelets, as rebanding of platelets from interfaces shows a wide variation in buoyant density when analysed in continuous gradients. It is concluded that analysis of platelet buoyant density in continuous Percoll gradients supports the view that platelet density, like platelet volume, is determined primarily during thrombocytopoiesis and that volume and density are largely independent elements of platelet heterogeneity.

Adult↗

The relationship between platelet and megakaryocyte volumes.

Planimetric megakaryocyte and nuclear areas were measured by histological techniques in rabbits subjected to 6 days of thrombocytopenia and in normal steady state function. A theoretical correction factor enables an estimate to be obtained of the actual megakaryocyte, megakaryocyte cytoplasm and nuclear volumes in these two states. The corresponding platelet volumes after 6 days of thrombocytopenia and in normal function were also measured. This enables the number of platelets produced by a single megakaryocyte (on average) to be computed directly in the two states of platelet production. The experiments showed that the volume of megakaryocyte cytoplasm increased significantly in stimulated platelet production. The number of platelets produced per megakaryocyte doubled and the mean platelet volume also increased during stimulated production. An explanation is given for the observed behaviour of platelet and megakaryocyte volumes.

Animals↗

Evidence for a theory of physical fragmentation of megakaryocytes, implying that all platelets are produced in the pulmonary circulation.

The mathematical description of a fragmentation mechanism which leads to log normal volume distribution is applied to platelet production from megakaryocyte cytoplasm. Large cytoplasmic fragments and whole megakaryocytes are released from the bone marrow into the circulation. Physical fragmentation of the cytoplasm occurs in the pulmonary circulation producing the observed heterogeneity of platelet volume. Experimental evidence is used to provide quantitative verification that physical fragmentation is the process which produces all platelets. With this theory the currently accepted concept of the predesignation of the platelet population by the demarcation membrane system in megakaryocyte cytoplasm becomes redundant.

Animals↗

Theoretical requirements for the density separation of platelets with comparison of continuous and discontinuous gradients.

In continuous density gradients platelets will approach their equilibrium position with exponential deceleration. The time taken to reach an acceptable approximation to equilibrium will depend upon platelet radius, density and medium viscosity. If centrifugation is stopped before equilibrium has been achieved then platelet "subpopulations" produced will not be density dependent. Discontinuous gradients take longer to reach equilibrium. Separation of platelets by density must conform to theoretical physical criteria.

Blood Platelets↗

Effect of acetylsalicylic acid on platelet aggregation and thromboxane B2 production in flowing aortic blood in the rat studied with a filter loop technique.

A method of measuring in vivo platelet function using a filter loop technique has been used to study platelet aggregation in response to Adenosine Diphosphate (ADP) and Sodium Arachidonate infusion in flowing aortic blood in the rat. ADP infusion produced reversible platelet aggregation in vivo with no change in thromboxane B2 (TXB2) levels whereas sodium arachidonate infusion resulted in virtually irreversible aggregation with a rise in TXB2 levels. Oral Acetylsalicylic Acid (ASA) in doses of 1-100 mg/kg had no effect on ADP induced aggregation but prevented platelet aggregation in vivo induced by sodium arachidonate and the concomitant rise in TXB2 levels.

Adenosine Diphosphate↗

Vincristine inhibits the synthesis of malondialdehyde by human platelets in vitro.

When platelet-rich plasma was preincubated with vincristine, a depression in malondialdehyde production was seen when compared with saline controls. Colchicine caused an increase in malondialdehyde production. If prostaglandins are important in tumor-cell metabolism, then vincristine might exert some of its cytotoxic effect by depressing prostaglandin production.

Adult↗

Platelets and malignancy. Rationale and experimental design for the VA Cooperative Study of RA-233 in the treatment of cancer.

Considerable evidence has accumulated in recent years which implicates blood coagulation reactions in the growth and spread of malignancy. In particular, platelets may accumulate on embolic tumor cells and facilitate their adhesion to the endothelium at distant sites perhaps by enhancing blood coagulation reactions. Alternatively, platelets may promote tumor cell proliferation by contributing a growth-promoting factor or through interactions mediated by prostaglandins. Inhibition of tumor growth and spread by platelet-inhibitory drugs has been demonstrated in several experimental tumor systems. Preliminary data suggest that similar effects may be seen in human malignancy. The purpose of this paper is to review relevant literature which provides the rationale for therapeutic trials of platelet-inhibitory drugs in human malignancy and to describe the experimental design for a trial involving one such drug, RA-233, in a recently established VA Cooperative Study.

Adenocarcinoma↗

Platelet sialic acid in malignant disease.

n-Acetylneuraminic acid (NANA) was measured in the platelets and serum of normal subjects, patients with malignant disease, and patients with acute myocardial infarction. The malignant disease group had a mean platelet NANA 24% below normal and a serum NANA 68% above normal. Both results were highly significant. Samples from patients with acute myocardial infarction showed slightly reduced platelet NANA and slightly raised serum NANA, neither change being significant. There was no correlation between platelet and serum NANA in the neoplastic group.

Blood Platelets↗

Effect of splenectomy of hepatic bilirubin clearance in patients with hereditary spherocytosis. Implications for the diagnosis of Gilbert's syndrome.

BRT and CBR were determined from studies of radiobilirubin kinetics in 14 patients undergoing splenectomy for hereditary spherocytosis. Studies were conducted both before and after the operation in order to assess the effects of the postsplenectomy fall in BRT on CBR. Splenectomy led to a doubling of the RBC-t1/2 from 13.0 +/- 1.7 (S.E.) days to 26.1 +/- 1.5 and a fall in BRT from 15.9 +/- 4.4 mg/kg/day to 4.3 +/- 0.9. In seven patients (group A) initially normal values for CBR were unaltered by surgery. In the remaining seven (group B), low preoperative values for CBR, suggestive of Gilbert's syndrome, uniformly improved after splenectomy, becoming normal in five patients. Nevertheless, family studies and reduced values for UDPGT activity supported the initial impression of concomitant Gilbert's syndrome in group B. These studies suggest the existence of a latent state for Gilbert's syndrome that, in some patients, may be unmasked by a hemolytic stress. As such, they have important implications for both pedigree analysis and incidence studies of this condition.

Adolescent↗

The effects of vincristine on platelet aggregation studied by a filter loop technique in the rat.

1 A method for measuring aggregation of platelets of adenosine diphosphate (ADP) is described using a filter inserted into the flowing aortic blood in the rat. 2 Repeated infusions of ADP resulted in a fall in the calculated aggregation index without significant changes in the platelet count. 3 Vincristine (0.05 mg/kg) intravenously caused significant inhibition of ADP-induced platelet aggregation. 4 Infusion of ADP caused some peripheral vasodilatation though it is unlikely that this contributed to the effects seen to any great extent.

Adenosine Diphosphate↗